Abstract Cytochrome P450 2D6 (CYP2D6) plays an important role in the metabolism and
bioactivation of about 25% of clinically used drugs including many antidepressants …

Pharmacogenomics (PGx) is the study of genetic influences on an individual's response to
medications. Improvements in the quality and quantity of PGx research over the past two …

Purpose The completion of the Human Genome Project has enhanced avenues for disease
prevention, diagnosis, and management. Owing to the shortage of genetic professionals …

Purpose Due to the diversity within Europe, the implementation of pharmacogenomic testing
in clinical practice faces specific challenges. In the context of the European …

Pharmacists are uniquely qualified to play essential roles in the clinical implementation of
pharmacogenomics. However, specific responsibilities and resources needed for these …

Purpose The current state of pharmacogenomics education for pharmacy students and
practitioners is discussed, and resources and strategies to address persistent challenges in …

Objective To develop, implement, and evaluate “Test2Learn” a program to enhance
pharmacogenomics education through the use of personal genomic testing (PGT) and real …

Purpose Widespread, quality genomics education for health professionals is required to
create a competent genomic workforce. A lack of standards for reporting genomics …

Adverse drug reactions (ADRs) account for a large proportion of hospitalizations among
adults and are more common in multimorbid patients, worsening clinical outcomes and …

Background The field of pharmacogenomics is rapidly advancing, but its adoption and
implementation remain slow and lacking. Lack of pharmacogenomics knowledge among …